Dendritic Cell Based Cancer Immunotherapy: in vivo Study with Mouse Renal Cell Carcinoma Model |
Lee, Hyunah
(The Cancer Center, Samsung Medical Center, Sungkyunkwan University School of Medicine)
Choi, Kwang-Min (The Cancer Center, Samsung Medical Center, Sungkyunkwan University School of Medicine) Baek, Soyoung (The Cancer Center, Samsung Medical Center, Sungkyunkwan University School of Medicine) Lee, Hong-Ghi (Division of Hematology and Oncology, Samsung Medical Center, Sungkyunkwan University School of Medicine) Jung, Chul-Won (Division of Hematology and Oncology, Samsung Medical Center, Sungkyunkwan University School of Medicine) |
1 | Steinman RM, Cohn ZA: Identificaion of a novel cell type in peripheral lymphoid organs of mice. I. Morphology, quantitation, tissue distribution. J Exp Med 137;1142-1162, 1973 DOI ScienceOn |
2 | Banchereau J, Steinman RM: Dendritic cells and the control of immunity. Nature 392;245-252, 1998 DOI ScienceOn |
3 | Inaba K, Young JW, Steinman RM : Direct activation of CD8+ cytotoxic T lymphocytes by dendritic cells. J Exp Med 166;182-194, 1987 DOI ScienceOn |
4 | Annual Report of the Central Cancer Registry in Korea, Central Cancer Registry Center, Ministry of Health and Welfare p42, 2001 |
5 | Gregorian SK., Battisto JR. : Immunosuppression in murine renal cell carcinoma II. Identification of responsible lymphoid cell phenotypes and examination of eliminatin of suppression. Cancer Immunol Immunothe 31(6);335-341, 1990 DOI ScienceOn |
6 | Inaba K, Inaba M, Deguchi M, Hagi K, Yasumizu R, Ikehara S, Muramatsu S, Steinman RM: Granulocytes, macrophages, and dendritic cells arise from a common major histocompatibility complex calss II-negative progenitor in mouse bone marrow. Proc Natl Acad Sci USA 90;3038-3042, 1993 DOI ScienceOn |
7 | Sallusto F, Lanzavecchia A: Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor-. J Exp Med 179;1109, 1994 DOI |
8 | Kalinski P, Schuitemarker JH, Hilkens CM, Wierenga EA, Kapsenberg ML: Final maturation of dendritic cells id associated with impaired responsiveness to IFN-gamma and to bacterial IL-12 inducers: decreased ability ofmature dendritic cells to produce IL-12 during the interaction with Th cells. J Immunol 162(6);3231-3236, 1999 |
9 | Young Robert C: Metastatic renal-cell carcinoma: what causes occasional dramatic regressions? The New England Journal of Medicine 338(18);1305-1306, 1998 DOI ScienceOn |
10 | Inaba K, Metlay JP, Crowley MT, Steinman RM: Dendritic cells pulsed with protein antigens in vitro can prime antigen-specific, MHC-restricted T cells in situ. J Exp Med 172;631-640, 1990 DOI ScienceOn |
11 | Hart DNJ: Dendritic cells: Unique leukocyte populations which control the primary immune response. Blood 90(9);3245-3287, 1997. PUBMED |
12 | Fernandez N et.al.: Dendritic cells directly trigger NK cell functions: Cross-talk relevant in innate anti-tumor immune responses in vivo. Nature Medicine 5(4);405-410, 1999 DOI ScienceOn |
13 | Divgi CR, Bander NH, Scott AM: Phase I/II radioimmunotherapy trial with iodine-131-labeled monoclonal antibody G250 in metastatic renal cell carcinoma. Clin Cancer Res 4;2729, 1998 |
14 | Wu L: Development of thymic and splenic dendritic cell populations from different hemopoietic precursors. Blood 98;3376-3382, 2001 DOI ScienceOn |
15 | Steinman RM: Prospects for immunotherapy directed to the T cell receptor in human autoimmune disease. Ann N Y Acad Sci 636;147-153, 1991 DOI PUBMED |
16 | Inaba K, Inaba M, Romani N, Aya H, Dequchi M, Ikehara S, Steinman RM: Generation of large numbers of dendritic cells from mouse bone marrow cultures supplemented with granulocyte/macrophage colony-stimulating factor. J Exp Med 176(6);1693-1702, 1992 DOI ScienceOn |
17 | Oosterwijk-Wakka J, Tiemessen D, Bleumer I, de Varies I, Jongmans W, Adema G, Debruyne F, de Mulder PH, Oosterwijk E, Mulders PF: Vaccination of patients with metastatic renal cell carcinoma with autologous dendritic cells pulsed with autologous tumor antigen in combination with interleukin-2: A phase I study. J Immunother 25(6);500-508, 2002 DOI |
18 | Grabmaier K, Vissier JLM, De Weuert MCA: Molecular cloning and immunogenicity of renal cell carcinoma-associated antigen G250. Int J Cancer 85;865, 2000 DOI ScienceOn |
19 | Muller L, Provenzani C, Faul C, Pawelec G: Recognition of chronic myelogeneous leukemia cells by autologous T lymphocytes primed in vitro against the patient's dendritic cells. Br J Haematol 112(3);740-748, 2001 DOI ScienceOn |
20 | Holtl L, Rieser C, Papesh C: Cellular and humoral immune responses in patients with metastatic renal cell carcinoma after vaccination with antigen pulsed dendritic cells. J Urol 161;777, 1999 DOI ScienceOn |
21 | Su Z, Dannull J, Heiser A, Yancey D, Pruitt S, Madden J, Coleman D, Niedzwiecki D, Gilboa E, Vieweg J: Imunological and clinical responses in metastatic renal cancer patients vaccinated with tumor RNA-transfected dendritic cells. Cancer Res 63;2127-2133, 2003 |
22 | Lotze, M., Shurin, M., Davis, I., Amoscato, A., and Storkus, W.:Dendritic cell based therapy of cancer. Dendritic Cells in Fundamental and Clinical Immunology. Ricciardi-Castagnoli ed., Plenum Press, New York, USA, 1997 |
23 | Rosenberg SA, Lotze MT, Mull LM: A progress report on the treatment of 157 patients with advanced cancer using lymphokine-activated killer cells and interleukin-2 or high-dose interleukin-2 alone. N Engl J Med 316;889, 1987 DOI ScienceOn |
24 | Ray PK, Raychaudhuri S, Allen P: Mechanism of regression of mammary adenocarcinomas in rats following plasma adsorption over protein A-containing staphylococcus aureus. Cancer Res 42;4970-4974, 1982. |
25 | Jonuleit H, Kuhn U, Muller G: Pro-inflammatory cytokines and prostaglandines induce maturaton of potent immunostimulatory dendritic cells under feta-calf-serum free conditions. Eur J Immunol 27(12); 3135-3142, 1999 DOI ScienceOn |
26 | Gregorian SK, Battisto JR: Immunosuppression in murine renal cell carcinoma.I. Characterization of extent, severity and sources. Cancer Immunol Immunothe 31(6);325-334, 1990 DOI ScienceOn |
27 | Shurin MR: Dendritic cells presenting tumor antigen. Cancer Immunol Immunother 43;158, 1996 DOI ScienceOn |
28 | Palucka K, Banchereau J: Dendritic cells: a link between innate and adaptive immunity. J Clin Immunol 19;12-25, 1999 DOI ScienceOn |
29 | Kurokawa T, Oelke M, Mackensen A: Induction and clonal expansion of tumor-specific cytotoxic T lymphocytes from renal cell carcinoma patients after stimulation with autologous dendritic cells loaded with tumor cells. Int J Cancer 91;749, 2001 DOI ScienceOn |
30 | Yoon HL, Singh KP, Ratner S, Reiners Jr JJ: Phorbol ester effects on splenic lymphocyte composition and cytotoxic T cell activities of SSIN mice: a strain deficient in CD8+ T cells. Carcinogenesis 17(12);2617-2624, 1996. DOI ScienceOn |
31 | Olweus J, BitMansour A, Warnke R: Dendritic cell ontogeny: a human dendritic cell lineage of myeloid origin. Proc Natl Acad Sci USA 94;12551-12556, 1997 DOI ScienceOn |
32 | Medial Research Council Renal Cancer Collaborators: Interferon- and survival in metastatic renal carcinoma: early results of a randomized controlled trial. Lancet 353;14, 1999 DOI ScienceOn |
33 | Flamand V, Sornasse T, Thielenabs K, Demanet C, Bakkus M, Bazin H, Thielemans C, Leo O, Urbain J, Moser M: Murine dendritic cells pulsed in vitro with tumor antigen induce tumor resistance in vivo. Eur J Immunol 24;605-610, 1994 DOI ScienceOn |
34 | Celluzzi C, Mayordomo JI, Storkus WJ, Lotze MT, Falo LD:Peptide-pulsed dendritic cells induce antigen-specific, CTLmediated protective tumor immunity. J Exp Med 183;283-288, 1996 DOI ScienceOn |
35 | Gitlitz B, Belldegrun A, Zisman A, Chao D, Pantuck A, Hinkel A, Mulders P, Moldawer N, Tso C, Figlin R: A pilot trial of tumor lysate-loaded dendritic cells for the treatment of metastatic renal cell carcinoma. J Immunother 26(5);412-419, 2003 DOI |
36 | Steinman RM, Inaba K: Myeloid dendritic cells. J Leuk Biol 66(2);205-208, 1999 DOI |
37 | Palucka K, Banchereau J: Linking innate and adaptive immunity. Nat Med 5;868-870, 1999 DOI ScienceOn |